Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the target of a significant growth in short interest in February. As of February 27th, there was short interest totaling 3,038 shares, a growth of 96.4% from the February 12th total of 1,547 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily volume of 15,092 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily volume of 15,092 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the shares of the stock are sold short.
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in HEAL. Daiwa Securities Group Inc. bought a new position in shares of Global X HealthTech ETF during the 3rd quarter valued at $11,239,000. WT Wealth Management lifted its stake in Global X HealthTech ETF by 10.1% in the fourth quarter. WT Wealth Management now owns 88,171 shares of the company’s stock worth $2,576,000 after purchasing an additional 8,066 shares during the last quarter. Flow Traders U.S. LLC purchased a new stake in Global X HealthTech ETF during the third quarter valued at about $368,000. Raymond James Financial Inc. purchased a new stake in Global X HealthTech ETF during the third quarter valued at about $274,000. Finally, Citadel Advisors LLC bought a new position in shares of Global X HealthTech ETF during the third quarter valued at about $216,000.
Global X HealthTech ETF Trading Down 3.0%
Shares of Global X HealthTech ETF stock traded down $0.76 on Thursday, hitting $24.86. 47,638 shares of the company traded hands, compared to its average volume of 15,297. Global X HealthTech ETF has a 12-month low of $24.48 and a 12-month high of $34.20. The company has a market cap of $33.06 million, a P/E ratio of 42.80 and a beta of 1.13. The firm’s 50-day simple moving average is $28.02 and its 200 day simple moving average is $30.23.
Global X HealthTech ETF Announces Dividend
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
Recommended Stories
- Five stocks we like better than Global X HealthTech ETF
- Proof that AI Stocks Could Crash 80%?
- Ex-Credit Suisse Insider Shares War-Proof Investment Strategy
- Gilder: Don’t Buy AI Stocks, Do This Instead
- The largest IPO in history is coming
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
